Butamirate indications
Oral
Cough suppression
Adult: For dry non-productive cough: As 50 mg tab: 2 or 3 tabs 8-12 hrly. As 7.5 mg/5 mL syr: 15 mL 4 times daily.
Child: As 50 mg tab:
Butamirate description
Each sustained-release film-coated tablet contains 50 mg of Butamirate. Each teaspoonful (5 mL) syrup contains 7.5 mg of Butamirate.
Butamirate dosage
The maximum duration of treatment without doctor's prescription is one week.
Tablet: Adolescents Over 12 Years of Age: 1 or 2 tablets daily.
Adults: 2 or 3 tablets daily at 8 or 12 hour intervals. To be swallowed whole.
Syrup: Children 3 to 6 Years of Age: One teaspoonful (5 mL) 3 times daily.
Children 6 to 12 Years of Age: Two (2) teaspoonfuls (10 mL) 3 times daily.
Adolescents Over 12 Years of Age: One tablespoonful (15 mL) 3 times daily.
Adults: 15 mL 4 times daily.
Wash and dry the graduated cup after each use and between different users.
Butamirate interactions
Sulphinpyrazone, a drug used as an antithrombotic agent and inhibitor of platelet aggregation has a potent side effect as a uricosuric agent. The uricosuric side effect increases the urinary excretion of uric acid effectively blocking hepatic conjugation. Tests show that Sulphinpyrazone’s effect on Butamirate is a reduction of liver function to 60% of normal without interfering with protein binding. Taking alpha-lipoic acid or chromium with tolbutamide may require a change in the drugs dosage. Use ephedra with caution when taking tolbutamide; ephedra can raise blood sugar levels.
Butamirate side effects
Adverse reactions are listed by system organ class and frequency. Frequencies are defined as: Very common (=1/10); common (=1/100 to <1/10); uncommon (=1/1,000 to <1/100); rare (=1/10,000 to <1/1,000); very rare (<1/10,000), or not known (cannot to be estimated from available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Nervous System Disorders: Rare: Somnolence.
Gastrointestinal Disorders: Rare: Nausea, diarrhea.
Skin and Subcutaneous Tissue Disorders: Rare: Urticaria.
Butamirate contraindications
You should not take tolbutamide if you have had an allergic reaction to it. Butamirate should not be taken if you are suffering from diabetic ketoacidosis (a life-threatening medical emergency caused by insufficient insulin and marked by excessive thirst, nausea, fatigue, pain below the breastbone, and fruity breath). In addition, Butamirate should not be used as the sole therapy in treating type 1 (insulin-dependent) diabetes.
Active ingredient matches for Butamirate:
Butamirate
| Unit description / dosage (Manufacturer) | Price, USD |
| Butamirate 1.5 mg/1 mL x 60 mL | |
| Butamirate 1.5 mg/1 mL x 120 mL | |
| Butamirate 1.5 mg/1 mL x 200 mL | |
List of Butamirate substitutes (brand and generic names): | |
| Butamir (Georgia) | |
| Butamirate 5 | |
| Butamirate 7.5 | |
| Butamirate Bevo (Greece) | |
| Butamirate Citrate | |
| Butamirate Citrate Bevo (Greece) | |
| Butamirate Citrate Norma (Greece) | |
| Butamirate Forte | |
| Butamirate Lavipharm (Greece) | |
| Butamirate Norma (Greece) | |
| Butamirato Mylan Generics (Italy) | |
| Butaxin 5 | |
| Butaxin 7.5 | |
| Butiran (Italy) | |
| Butirol (Turkey) | |
| Butirol Fort (Turkey) | |
| Butrin (Greece) | |
| Buvastin (Greece) | |
| Chemisolv (Greece) | |
| Chributan (Greece) | |
| Codactiv (Turkey) | |
| Codactiv Fort (Turkey) | |
| Codexine-R (Greece) | |
| Codimin (Greece) | |
| Cofmed (Philippines) | |
| Cofmed SR tab 50 mg 40's (Medhaus) | |
| Cofmed syr 7.5 mg/5 mL 60 mL x 1's (Medhaus) | |
| Cough Cut (Egypt) | |
| Cutmirat (Turkey) | |
| Cyne (Greece) | |
| Deconil (Bangladesh) | |
| DemoTussol (Switzerland) | |
| Drops; Oral; Butamirate Citrate 22.5 mg / ml (Vifor) | |
| Syrup; Oral; Butamirate Citrate 22.5 mg / 15 ml (Vifor) | |
| Tablet; Oral; Butamirate Citrate 22.5 mg (Vifor) | |
| Devix (Greece) | |
| Doctamine (Greece) | |
| Dosodos (Argentina) | |
| Dricod (Tunisia) | |
| Drosten (Greece) | |
| Ellisek (Greece) | |
| Ellisek-S (Greece) | |
| Gertotus (Greece) | |
| Gertotuss (Greece) | |
See 167 substitutes for Butamirate | |
Reviews
The results of a survey conducted on ndrugs.com for Butamirate are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Butamirate. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yet2 consumers reported price estimates
Was the price you paid to purchase the drug reasonable? Did you feel it was expensive?The below mentioned numbers have been reported by ndrugs.com website users about whether the Butamirate drug is expensive or inexpensive. There is a mixed opinion among users. The rating about the cost of the drug depends on factors like which brand drug the patient purchased, how effective it was for the price paid, the country or place the drug is marketed, and the economic condition of the patient. The users who feel the drug is expensive can look for an alternative brand drug or a generic drug to save the cost.
| Users | % | ||
|---|---|---|---|
| Not expensive | 1 | 50.0% | |
| Expensive | 1 | 50.0% | |
1 consumer reported time for results
To what extent do I have to use Butamirate before I begin to see changes in my health conditions?As part of the reports released by ndrugs.com website users, it takes > 3 month and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Butamirate. To get the time effectiveness of using Butamirate drug by other patients, please click here.
| Users | % | ||
|---|---|---|---|
| > 3 month | 1 | 100.0% | |
3 consumers reported age
| Users | % | ||
|---|---|---|---|
| 30-45 | 1 | 33.3% | |
| 46-60 | 1 | 33.3% | |
| 16-29 | 1 | 33.3% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
